The ‘best’ vaccine: how does Pfizer fare against the others?
The brand approved for emergency use in SA wins for efficacy but loses for its dosing regimen
23 March 2021 - 20:34
The brand approved for emergency use in SA wins for efficacy but loses for the dosing regimen
This article is reserved for Sunday Times subscribers.
A subscription gives you full digital access to all Sunday Times content.
Please visit SundayTimes.co.za in your desktop to view our latest subscription options.
Already subscribed? Simply sign in below.
Sign InQuestions or problems? Email helpdesk@timeslive.co.za or call 0860 52 52 00.